Kellie Wallace-Wilding, MD
Family Medicine · Jackson, TNNPI 1063518629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 82.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $206 and has fallen 78.4% since, to $45 in 2024. That places this record below the midpoint for family medicine clinicians in TN, where the typical reported total is $470.
Across 62 payments — averaging $6.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$350
- AbbVie$34
- Teleflex LLC$25
- Impel Pharmaceuticals Inc.$17
Across 10 payments — averaging $9336.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$80K
- Cue Health Inc.$7K
- Exact Sciences$6K
What the payments were for
- Food & beverage$426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $350 |
| AbbVie | 2 | $34 |
| Teleflex LLC | 1 | $25 |
| Impel Pharmaceuticals Inc. | 1 | $17 |
How this compares
$426 in reported general payments places this provider in the 45th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 214 | $196,313 |
| OzempicSemaglutide | 100 | $114,994 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $86,052 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 38 | $63,745 |
| MounjaroTirzepatide | 29 | $49,581 |
| JardianceEmpagliflozin | 35 | $47,944 |
| XareltoRivaroxaban | 63 | $45,401 |
| EntrestoSacubitril/Valsartan | 56 | $44,657 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $34,005 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 34 | $33,964 |
| FarxigaDapagliflozin Propanediol | 32 | $32,125 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 24 | $25,682 |
| Xtampza ErOxycodone Myristate | 15 | $17,048 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $14,711 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $12,922 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $350 | $114,994100 claims |
| AbbVieLinzess, Synthroid | $34 | $17,34788 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Jackson
- Grant StudebakerJackson$27K
- Elizabeth LondinoJackson$17K
- Timothy HaydenJackson$17K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.